PLoS ONE (Jan 2023)

Pangenomic antiviral effect of REP 2139 in CRISPR/Cas9 engineered cell lines expressing hepatitis B virus surface antigen

  • Léna Angelo,
  • Andrew Vaillant,
  • Matthieu Blanchet,
  • Patrick Labonté

Journal volume & issue
Vol. 18, no. 11

Abstract

Read online

No abstracts available.